El diagnóstico de la infección por el virus de la hepatitis C en España: una oportunidad para mejorar

Enfermedades Infecciosas y Microbiologia Clinica - Tập 37 - Trang 231-238 - 2019
Javier Crespo1, Pablo Lázaro de Mercado2, Antonio Javier Blasco Bravo3, Antonio Aguilera Guirao4, Javier García-Samaniego Rey5, José María Eiros Bouza6, José Luis Calleja Panero7, Federico García8
1Servicio de Aparato Digestivo, Hospital Universitario Marqués de Valdecilla, IDIVAL, Facultad de Medicina, Universidad de Cantabria, Santander, España
2Investigador independiente en servicios de salud, Madrid, España
3Investigador independiente en servicios de salud, Rivas-Vaciamadrid. Madrid, España
4Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago, Xerencia de Xestión Integrada de Santiago, Santiago de Compostela, A Coruña, España
5Servicio de Aparato Digestivo, Hospital Universitario La Paz, Madrid, CIBERehd. IdiPAZ, Madrid, España
6Servicio de Microbiología, Hospital Universitario Río Hortega, Valladolid, España
7Servicio de Aparato Digestivo, Hospital Universitario Puerta de HierroUniversidad Autónoma de Madrid, Majadahonda, España
8Servicio de Microbiología, Hospital Universitario San Cecilio, Instituto Investigación Biosanitaria Ibs, Granada, España

Tài liệu tham khảo

2017, Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study, Lancet Gastroenterol Hepatol., 2, 161, 10.1016/S2468-1253(16)30181-9 WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO [consultado 28 Ene 2018]. Disponible en: https://www.finddx.org/wp-content/uploads/2017/02/WHO-guidelines-HBV-HCV-testing-Feb2017.pdf Lavin, 2017, Prevalence of hepatitis C in the Spanish population. The prevhep study (ETHON cohort), J Hepatology, 66, S272, 10.1016/S0168-8278(17)30857-7 Rodríguez-Tajesa S, Dacalb Y, Collazos C, Frías MC, Vidal Benedee MJ, Janéd M, et al. Estudio de prevalencia de infección por los virus de la hepatitis B y C en Cataluña. 42 Congreso de la Asociación Española de Estudio del Hígado. Madrid, 15-17 de febrero de 2017. Li, 2017, Current therapy for chronic hepatitis C: The role of direct-acting antivirals, Antiviral Res., 142, 83, 10.1016/j.antiviral.2017.02.014 2017, EASL recommendations on treatment of hepatitis C 2016, J Hepatol., 66, 153, 10.1016/j.jhep.2016.09.001 2015, Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus, Hepatology., 62, 932, 10.1002/hep.27950 World Health Organisation, 2017a. Hepatitis C fact sheet [consultado 29 Ene 2018]. Disponible en: http://www.who.int/mediacentre/factsheets/fs164/en/ Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO [consultado 29 Ene 2018]. Disponible en: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf Buti, 2017, Eliminación de la hepatitis C en España: Adaptación de un modelo matemático de salud pública partiendo del plan estratégico para el abordaje de la hepatitis C en el Sistema Nacional de Salud, Med Clin (Barc)., 148, 277, 10.1016/j.medcli.2016.12.018 The Lancet. Eliminating viral hepatitis: time to match visions with action. Lancet. 2017;390:2121. National Academies of Sciences, Engineering, and Medicine. A national strategy for the elimination of hepatitis B and C: Phase two report. Washington, DC: The National Academies Press; 2017. Ministerio de Sanidad, Servicios Sociales e Igualdad. Plan estratégico para el abordaje de la hepatitis C en el sistema nacional de salud. Madrid, 21 de mayo de 2015. Denniston, 2014, Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010, Ann Intern Med., 160, 293, 10.7326/M13-1133 Grebely, 2017, Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: A cohort study, Lancet Gastroenterol Hepatol., 2, 514, 10.1016/S2468-1253(17)30075-4 Peeling, 2017, The future of viral hepatitis testing: Innovations in testing technologies and approaches, BMC Infect Dis., 17, 699, 10.1186/s12879-017-2775-0 Grebely, 2017, Hepatitis C point-of-care diagnostics: In search of a single visit diagnosis, Expert Rev Mol Diagn., 17, 1109, 10.1080/14737159.2017.1400385 Assoumou, 2018, Cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings, Clin Infect Dis., 66, 376, 10.1093/cid/cix798 Chhatwal, 2018, Hepatitis C screening: From modeling to public health policy, Clin Infect Dis., 66, 385, 10.1093/cid/cix800 Ministerio de Sanidad, Servicios Sociales e Igualdad. Catálogo Nacional de Hospitales 2017. Actualizado a 31 de diciembre de 2016 [consultado 11 Jul 2017]. Disponible en: https://www.msssi.gob.es/ciudadanos/prestaciones/centrosServiciosSNS/hospitales/home.htm Harris, 2016, Finding the undiagnosed: A qualitative exploration of hepatitis C diagnosis delay in the United Kingdom, J Viral Hepat., 23, 479, 10.1111/jvh.12513 Yau, 2015, Rate, delay and predictors of hepatitis C treatment in British Columbia, Can J Gastroenterol Hepatol., 29, 315, 10.1155/2015/120132 Levi, 2016, Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: Results of the HEPscreen Project, Eur J Public Health., 26, 561, 10.1093/eurpub/ckw054 Casas, 2017, Diagnóstico del virus de la hepatitis C: impacto de la actitud del servicio de Microbiología en la cascada del tratamiento, Enferm Infecc Microbiol Clin., 35, 237 Greenaway, 2017, A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, Canada, BMC Infect Dis., 17, 140, 10.1186/s12879-017-2242-y Grassi, 2017, Hepatitis C in injection drug users: It is time to treat, World J Gastroenterol., 23, 3569, 10.3748/wjg.v23.i20.3569 Konerman, 2016, Hepatitis C treatment and barriers to eradication, Clin Transl Gastroenterol., 7, e193, 10.1038/ctg.2016.50 Parry, 2017, One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling, BMC Infect Dis., 17, 705, 10.1186/s12879-017-2774-1 Rogal, 2017, The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample, Implement Sci., 12, 60, 10.1186/s13012-017-0588-6 Clark, 2005, Hepatitis C identification and management by family physicians, Fam Med., 37, 644 Alados, 2017, Situación actual del diagnóstico de la infección por el virus de la hepatitis C en Andalucía, Enferm Infecc Microbiol Clin., 35, 25